The majority of patients with type 2 diabetes (T2D) have less than ideal metabolic control despite our greater understanding of the underlying pathophysiologic mechanisms of hyperglycemia and the ...
The approval of medicines called “glucagon-like peptide (GLP-1) agonists” has led to major changes in how type 2 diabetes is managed. These medicines work in a different way than other medicines used ...
Download for updates and be a part of the revolution in Endocrinology and Metabolic Disorders Care @ Type 2 Diabetes Clinical Trials Assessment The Type 2 Diabetes Pipeline Report provides a disease ...
New research reveals that type 2 diabetes doesn’t just raise the risk of heart disease, it physically reshapes the heart ...
In a recent review published in the journal Diabetes Care, Daniel J. Drucker of Lunenfeld-Tanenbaum Research Institute, University of Toronto, evaluated the efficacy and safety of glucagon-like ...
ScienceAlert on MSN
Caffeine in Your Blood Might Affect Body Fat And Diabetes Risk, Study Shows
The levels of caffeine in your blood could affect the amount of body fat you carry, a factor that in turn could determine ...
PUNE, India, June 6, 2017 /PRNewswire-iReach/ -- Pharmaceutical latest report of Type 2 Diabetes - Pipeline Review, H1 2017 adds on RnRMarketResearch.com. The report provides an overview of the Type 2 ...
Having persistently high liver enzyme levels present in early adulthood is a strong predictor of type 2 diabetes risk. Learn ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback